ATE236977T1 - Verwendung einer rekombinanten dna für die herstellung eines medikaments, wobei die rekombinante dna eine dna umfasst, die die sm1- isoform des proteins der schweren kette von myosin der glatten muskulatur codiert - Google Patents

Verwendung einer rekombinanten dna für die herstellung eines medikaments, wobei die rekombinante dna eine dna umfasst, die die sm1- isoform des proteins der schweren kette von myosin der glatten muskulatur codiert

Info

Publication number
ATE236977T1
ATE236977T1 AT96901112T AT96901112T ATE236977T1 AT E236977 T1 ATE236977 T1 AT E236977T1 AT 96901112 T AT96901112 T AT 96901112T AT 96901112 T AT96901112 T AT 96901112T AT E236977 T1 ATE236977 T1 AT E236977T1
Authority
AT
Austria
Prior art keywords
recombinant dna
dna
heavy chain
smooth muscle
isoform
Prior art date
Application number
AT96901112T
Other languages
English (en)
Inventor
Kazuhide Hasegawa
Emi Arakawa
Shoji Oda
Yuzuru Matsuda
Katsuhito Takahashi
Michihiro Sugahara
Haruo Ishiyama
Original Assignee
Vessel Res Lab Co Ltd
Osaka Prefecture
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vessel Res Lab Co Ltd, Osaka Prefecture filed Critical Vessel Res Lab Co Ltd
Application granted granted Critical
Publication of ATE236977T1 publication Critical patent/ATE236977T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4716—Muscle proteins, e.g. myosin, actin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Cardiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT96901112T 1995-01-25 1996-01-25 Verwendung einer rekombinanten dna für die herstellung eines medikaments, wobei die rekombinante dna eine dna umfasst, die die sm1- isoform des proteins der schweren kette von myosin der glatten muskulatur codiert ATE236977T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP1008595 1995-01-25
PCT/JP1996/000134 WO1996023069A1 (en) 1995-01-25 1996-01-25 Recombinant dna prepared by integrating dna that codes for myosin heavy-chain sm1 isoform protein into vector dna, and microorganism and arteriosclerosis remedy both containing the recombinant dna

Publications (1)

Publication Number Publication Date
ATE236977T1 true ATE236977T1 (de) 2003-04-15

Family

ID=11740510

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96901112T ATE236977T1 (de) 1995-01-25 1996-01-25 Verwendung einer rekombinanten dna für die herstellung eines medikaments, wobei die rekombinante dna eine dna umfasst, die die sm1- isoform des proteins der schweren kette von myosin der glatten muskulatur codiert

Country Status (13)

Country Link
US (1) US6593304B1 (de)
EP (1) EP0806477B1 (de)
JP (1) JP3092944B2 (de)
KR (1) KR19980701695A (de)
AT (1) ATE236977T1 (de)
AU (1) AU711757B2 (de)
CA (1) CA2211468A1 (de)
DE (1) DE69627307T2 (de)
FI (1) FI973104A7 (de)
HU (1) HUP9801762A1 (de)
NO (1) NO973421L (de)
NZ (1) NZ300270A (de)
WO (1) WO1996023069A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11285333A (ja) * 1998-02-05 1999-10-19 Vessel Research Laboratory:Kk 変異型平滑筋ミオシン重鎖遺伝子を有する非ヒト動物の胚幹細胞および非ヒト動物
CN1321672A (zh) * 2000-04-29 2001-11-14 上海博德基因开发有限公司 一种新的多肽——人肌球蛋白重链12－14和编码这种多肽的多核苷酸
US6974688B2 (en) * 2001-08-10 2005-12-13 Cytokinetics, Inc. Human smooth muscle myosin heavy chain
US10590452B2 (en) 2017-12-20 2020-03-17 University Of Seoul Industry Cooperation Foundation DNA-Mn hybrid particles and method of manufacturing the same

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0646841A (ja) 1992-07-24 1994-02-22 Kyowa Hakko Kogyo Co Ltd トランスフェリン非要求性細胞

Also Published As

Publication number Publication date
AU4496196A (en) 1996-08-14
WO1996023069A1 (en) 1996-08-01
NO973421L (no) 1997-09-22
EP0806477B1 (de) 2003-04-09
EP0806477A4 (de) 2000-01-05
EP0806477A1 (de) 1997-11-12
DE69627307T2 (de) 2004-03-04
FI973104L (fi) 1997-09-24
HUP9801762A1 (hu) 1998-11-30
DE69627307D1 (de) 2003-05-15
AU711757B2 (en) 1999-10-21
NZ300270A (en) 1998-09-24
JP3092944B2 (ja) 2000-09-25
KR19980701695A (ko) 1998-06-25
NO973421D0 (no) 1997-07-24
US6593304B1 (en) 2003-07-15
FI973104A0 (fi) 1997-07-24
FI973104A7 (fi) 1997-09-24
CA2211468A1 (en) 1996-08-01

Similar Documents

Publication Publication Date Title
DE60023870T2 (de) Verfahren zur herstellung von 3-aryloxy-3-arylpropylamine und deren zwischenprodukte
DE3854950D1 (de) Vascular-antikoagulierende Proteine, DNA die diese kodieren, Verfahren zu deren Herstellung sowie deren Verwendung
FI901289A7 (fi) Muistia ja oppimista parantava tai kognitiivisten tai psykoottisten häiriöiden hoidossa käytettävä koostumus, joka sisältää D-sykloseriiniä ja D-alaniinia
DE59303365D1 (de) Derivate in der vitamin d-reihe mit modifikationen in der 20 position, verfahren zu ihrer herstellung, zwischenprodukte für dieses verfahren, diese derivate enthaltende pharmazeutische präparate sowie deren verwendung zur herstellung von arzneimitteln
MXPA02011656A (es) Moleculas de acido nucleico nrg-2, polipeptidos, y metodos de diagnostico y terapeuticos.
TR199902124T2 (xx) �ltihapl� hastal�klar�n tedavisinde yararl� k���k molek�ller.
ATE46718T1 (de) Hybride menschliche leukozyten-interferone, verfahren zu deren mikrobieller herstellung, zwischenverbindungen dafuer und dieselben enthaltende zusammensetzungen.
ATE163537T1 (de) Kosmetische zusammensetzung, enthaltend als reduktionsmittel ein n-mercaptoalkylalkandiamid oder eines seiner kosmetisch verträglichen salze
DE69536039D1 (de) Wirtszelle enthaltend ein rekombinantes Virus, welches ein Antigen exprimiert und ein rekombinantes Virus, welches ein immunstimulatorisches Molekül exprimiert
DE69635207D1 (de) Auf Chromosom 1 lokalisiertes Gen dessen Genprodukt mit der Alzheimerschen Krankheit assoziiert ist.
DE69329195D1 (de) Rekombinante dna moleküle die aminopeptidase enzyme kodieren und ihre anwendung für die herstellung von impfstoffen gegen helminth infektionen
DE69926254D1 (de) Verwendung von radioliganden zum screening von inhibitoren der herstellung von beta-amyloid peptiden
ATE253128T1 (de) Katalytische nukleinsäuren und deren medizinische verwendung
DE69011151D1 (de) Ultraviolettunterdrückte Lichtquelle, dafür verwendeter Beschichtungsstoff und Verfahren zu seiner Herstellung.
DK0892849T3 (da) Fremgangsmåde til anvendelse af obese-genet og dets genprodukt til stimulering af hæmatopoietisk udvikling
ATE240743T1 (de) Verfahren und substanzen gegen protozoen
WO2004019893A3 (en) Modulators of angiogenesis
EE200100472A (et) Polüpeptiid, antikehad, lahustuv polüpeptiid, polü- või oligonukleotiid ja meetod diferentsiaalseltekspresseerunud DNA järjestuste spetsiifiliseks identifitseerimiseks
PT948604E (pt) Produtos e metodos relacionados com pyk2
HUP0100668A2 (hu) Virulenciával kapcsolatos nukleinsavszekvenciák és alkalmazásuk
DE60112136D1 (de) Verfahren zur Herstellung von 1-(2,5-Diaminophenyl)ethanol und dessen Verwendung für oxidative Färbeprozesse
DE69319012D1 (de) Protein mit Knochenbildungs-Eigenschaften und Verfahren zu seiner Herstellung
ATE236977T1 (de) Verwendung einer rekombinanten dna für die herstellung eines medikaments, wobei die rekombinante dna eine dna umfasst, die die sm1- isoform des proteins der schweren kette von myosin der glatten muskulatur codiert
ATE216251T1 (de) Myrteextrakt enthaltendes haarpflegemittel, verfahren zur herstellung und verwendung insbesondere für eine antischuppenbehandlung
DK0773290T3 (da) Hidtil ukendt LDL-receptoranalog-protein og det gen, der koder derfor

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties